UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature medicine, ISSN 1078-8956, 10/2009, Volume 15, Issue 10, pp. 1149 - 1152
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Piperazines - history | History, 21st Century | Protein Kinase Inhibitors - history | United States | History, 20th Century | Humans | Awards and Prizes | Clinical Trials as Topic | Piperazines - therapeutic use | Imatinib Mesylate | Neoplasms - drug therapy | Research - trends | Pyrimidines - history | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Benzamides | Forecasts and trends | Research | Drug therapy | Oncology, Experimental | Leukemia in children | Cancer | Oncology | Chemotherapy | Biomedical research | Brian J Druker | Leukemia | Index Medicus | Druker
Journal Article
2011, 12th ed., McGraw-Hill's AccessMedicine, ISBN 0071624422, 2047
eBook
Cancer cell, ISSN 1535-6108, 09/2014, Volume 26, Issue 3, pp. 428 - 442
Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Fusion Proteins, bcr-abl - chemistry | Catalytic Domain | Humans | Imidazoles - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Antineoplastic Agents - therapeutic use | Imidazoles - pharmacology | Mutation, Missense | Pyridazines - pharmacology | Antineoplastic Agents - chemistry | Molecular Dynamics Simulation | Pyridazines - chemistry | Drug Resistance, Neoplasm - genetics | Fusion Proteins, bcr-abl - genetics | Protein Kinase Inhibitors - therapeutic use | Treatment Failure | Protein Binding | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology | Imidazoles - therapeutic use | Philadelphia Chromosome | Pyridazines - therapeutic use | Leukemia | Genetic aspects | Cancer | Index Medicus | Medicin och hälsovetenskap
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2001, Volume 61, Issue 12, pp. 1775 - 1776
Journal Article
Blood, ISSN 0006-4971, 12/2008, Volume 112, Issue 13, pp. 4808 - 4817
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Piperazines - history | History, 21st Century | History, 20th Century | Humans | Biomedical Research - history | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Pyrimidines - pharmacology | Drug Delivery Systems - history | Imatinib Mesylate | Piperazines - pharmacology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - history | Pyrimidines - history | Benzamides | Philadelphia Chromosome - drug effects | Drug Delivery Systems - methods | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 10, pp. 917 - 927
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Interferon-alpha - therapeutic use | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Antineoplastic Agents - therapeutic use | Cross-Over Studies | Young Adult | Imatinib Mesylate - therapeutic use | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Imatinib Mesylate - adverse effects | Adolescent | Intention to Treat Analysis | Survival Analysis | Adult | Female | Aged | Cytogenetic Analysis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Care and treatment | Chronic myeloid leukemia | Patients | Health aspects | Prescription drugs | α-Interferon | Imatinib | Cytarabine | Myeloid leukemia | Medical prognosis | Interferon | Kinases | Survival | Index Medicus | Abridged Index Medicus | Inhibidors enzimàtics | Hematologia | Enzyme inhibitors | Hematology | Leucèmia mieloide
Journal Article
The New England journal of medicine, ISSN 0028-4793, 12/2019, Volume 381, Issue 24, pp. 2315 - 2326
d_article_not_yet_freely_accessible | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Niacinamide - analogs & derivatives | Follow-Up Studies | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - administration & dosage | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Aged, 80 and over | Niacinamide - pharmacokinetics | Adult | Female | Antineoplastic Agents - pharmacokinetics | Pyrazoles - pharmacokinetics | Pyrazoles - adverse effects | Niacinamide - adverse effects | Logistic Models | Niacinamide - administration & dosage | Fusion Proteins, bcr-abl - genetics | Pyrazoles - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Aged | Mutation | Tyrosine | Thrombocytopenia | Headache | Myeloid leukemia | Leukemia | Arthralgia | Pancreatitis | Chronic myeloid leukemia | Lipase | Kinases | Patients | Philadelphia chromosome | Side effects | Allosteric properties | Cytogenetics | Protein-tyrosine kinase | Binding sites | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2003, Volume 348, Issue 11, pp. 994 - 1004
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Blood. Blood coagulation. Reticuloendothelial system | Pharmacology. Drug treatments | Prospective Studies | Humans | Leukemia, Myeloid, Chronic-Phase - drug therapy | Middle Aged | Male | Survival Rate | Antineoplastic Agents - therapeutic use | Piperazines - therapeutic use | Antineoplastic Agents - administration & dosage | Imatinib Mesylate | Cytarabine - administration & dosage | Disease Progression | Interferon-alpha - administration & dosage | Leukemia, Myeloid, Chronic-Phase - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Adolescent | Adult | Female | Aged | Benzamides | Chronic myeloid leukemia | Pharmaceutical industry | Drug therapy | Product information | Clinical trials | Leukemia | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article